SCHEDULE: FMR LLC Discloses 11.8% Stake in LENZ THERAPEUTICS

FMR LLC and its affiliates, including Abigail P. Johnson, reported beneficial ownership of 11.8% of LENZ THERAPEUTICS INC common stock as of December 31, 2025.

Summary

• FMR LLC, a parent holding company, and Abigail P. Johnson, an individual, jointly reported beneficial ownership of 3,702,717.53 shares of LENZ THERAPEUTICS INC common stock.
• This aggregate ownership represents 11.8% of the total outstanding common stock of LENZ THERAPEUTICS INC.
• FMR LLC holds sole voting power over 3,699,619.61 shares and sole dispositive power over 3,702,717.53 shares.
• Abigail P. Johnson holds sole dispositive power over 3,702,717.53 shares, with no sole or shared voting power directly attributed.
• Fidelity Growth Company Commingled Pool, an entity associated with FMR LLC, is known to have an interest of 1,643,269.00 shares, representing 5.3% of the total outstanding common stock.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant stake by a reputable institutional investor like FMR LLC typically indicates a belief in the company's value and potential, without providing direct operational or financial performance updates.

Positives

• Significant institutional investment by FMR LLC, a major financial services firm, signals confidence in LENZ THERAPEUTICS INC.
• The substantial 11.8% stake indicates a long-term interest from a prominent institutional investor.

Industry Context

StockSavvy.ai notes that a significant increase in institutional ownership by a major asset manager like FMR LLC can often be interpreted by the market as a vote of confidence in a company's strategic direction and future prospects, particularly for a therapeutics company where long-term development and market potential are key drivers.

Comparison to Industry Standards

• This filing is an ownership disclosure and does not contain performance metrics or operational results that can be directly compared to industry standards or specific competitor projects.

Stakeholder Impact

• Shareholders: The increased institutional ownership may instill greater confidence among existing and potential shareholders, potentially stabilizing or positively influencing the stock price due to perceived institutional backing.

Key Dates

Recommendation

The disclosure of a substantial 11.8% stake by FMR LLC suggests institutional confidence in LENZ THERAPEUTICS INC. While this is a positive signal, the filing itself does not provide new operational or financial performance data to warrant an immediate 'buy' or 'sell' recommendation. It primarily indicates a significant long-term investment by a major player, suggesting a 'hold' position to observe future company developments and market reactions.

Keywords

LENZ THERAPEUTICS INC, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Institutional Investor, Common Stock, Schedule 13G, Equity Stake, Fidelity